CORIX BIOSCIENCE, INC.: 10-Q/A filed 2017-11-09
What CORIX BIOSCIENCE, INC. reported in its quarterly report amendment filed 2017-11-09 (fiscal Q3 2016): 21 published measures, 52 facts as tagged in accession 0001659173-17-000494.
This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.
This filing
- Form
- 10-Q/A (quarterly report amendment)
- Filed
- 2017-11-09
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001659173-17-000494 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CORIX BIOSCIENCE, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 12,052,298 | USD | |
| At 2015-12-31 | 9,417,532 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 6,013,348 | USD | |
| At 2015-12-31 | 4,414,368 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,377,032 | USD | |
| At 2015-12-31 | 4,471,260 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 90,646 | USD | |
| At 2015-12-31 | 199,570 | USD | |
| At 2015-09-30 | 424,684 | USD | |
| At 2014-12-31 | 304,371 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -1,548,126 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -4,290,611 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -1,124,089 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -2,291,653 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -1,500,379 | USD | 274 |
| 2015-01-01 to 2015-09-30 | -1,969,511 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 175,695 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 503,210 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 133,444 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 327,190 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 1,208,279 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 3,011,930 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 183,176 | USD | 274 |
| 2015-01-01 to 2015-09-30 | -922,106 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -12,285,258 | USD | |
| At 2015-12-31 | -7,994,647 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,734 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 2,601,058 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 477,000 | USD | 273 |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 6,188 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 1,723,821 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 4,798,802 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 1,257,533 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,690,136 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 9,191,907 | shares | |
| At 2015-12-31 | 7,566,815 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 16,570,371 | USD | |
| At 2015-12-31 | 12,390,239 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 6,038,950 | USD | |
| At 2015-12-31 | 5,003,164 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -1,548,126 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -4,290,611 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -1,124,089 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -2,291,653 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 1,588,536 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 4,402,634 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 1,143,678 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,097,037 | USD | 273 |
Proceeds from issuing common stock
Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 509,600 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 2,926,505 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -6,188 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 0 | USD | 273 |
Inspect the source
- Entity
- CORIX BIOSCIENCE, INC. / CIK 0001433821
- Captured
- SEC response SHA-256
83bf56b0a57d4bb31413a41a5bf482e2202ff4890c0e95b25620534c9d887dab
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001433821.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))